A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways. Kim B-W, More S V, Yun Y-S, Ko H-M, Kwak J-H, Lee H, Suk K, Kim I-S, Choi D-K Acta Pharmacol Sin. 2016 Feb 1. PMID: 26838070. Abstract CommentRecommendBookmarkWatch